Head and Neck Radiation Therapy

References

1. Head and Neck Cancers Version 3.2021.
   (Available at:)
   https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdfhttps://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf

   Date: 2021
   (Accessed January 1, 2022)
   View in Article

   • Google Scholar
2. • Precise Bite Patient Re-Positioner
   Precise bite patient re-positioner. (n.d.).
   (Available at:)
   https://civcort.com/ro/head-neck/precise-bite/Precise-Bite-Patient-Re-Positioner.htm
   (Accessed January 1, 2022)
   View in Article

   • Google Scholar
3. • Stieb S.
   • Perez-Martinez I.
   • Mohamed A.S.R.
   • et al.
   The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors.
   Clin translational Radiat Oncol. 2020; 24: 71-78
   View in Article

   • Google Scholar
4. • Grégoire V.
   • Evans M.
   • Le Q.T.
   • et al.
   Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiotherapy and oncology.
   J Eur Soc Ther Radiol Oncol. 2018; 126: 3-24
   View in Article

   • Google Scholar
5. • Lee A.W.
   • Ng W.T.
   • Pan J.J.
   • et al.
   International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.
   Radiother Oncol. 2018; 126: 25-36
   View in Article

   • Google Scholar
6. Tata Medical Center RSNA AVARO anatomy project. econtour.org. (n.d.).
   (Available at:)
   https://www.econtour.org/cases/83
   (Accessed January 1, 2022)
   View in Article

   • Google Scholar
7. • Ramasamy S.
   • Murray L.J.
   • Cardale K.
   • et al.
   Quality assurance peer review of head and neck contours in a large cancer centre via a weekly meeting approach.
   Clin Oncol (Royal Coll Radiol). 2019; 31: 344-351
   View in Article

   • Google Scholar
8. • Fong C.
   • Sanghera P.
   • Good J.
   • et al.
   Implementing head and neck contouring peer review without pathway delay: the on-demand approach.
   Clin Oncol (R Coll Radiol). 2017; 29: 841-847
   View in Article

   • Google Scholar
9. • Zairis S.
   • Margalit D.N.
   • Royce T.J.
   • et al.
   Prospective analysis of radiation oncology image and plan-driven peer review for head and neck cancer.
   Head Neck. 2017; 39: 1603-1608
   View in Article

   • Google Scholar
10. • Bar Ad V.
    • Weinstein G.
    • Dutta P.R.
    • et al.
    Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy.
    Head Neck. 2010; 32: 173-177
    View in Article

    • Google Scholar
11. • Milazzo-Kiedaisch C.A.
    • Itano J.
    • Dutta P.R.
    Role of gabapentin in managing mucositis pain in patients undergoing radiation therapy to the head and neck.
    Clin J Oncol Nurs. 2016; 20: 623-628
    View in Article

    • Google Scholar
12. • Jayakrishnan R.
    • Chang K.
    • Ugurluer G.
    • et al.
    Doxepin for radiation therapy-induced mucositis pain in the treatment of oral cancers.
    Oncol Rev. 2015; 9: 290
    View in Article

    • Google Scholar
13. • van Imhoff L.C.
    • Kranenburg G.G.
    • Macco S.
    • Nijman N.L.
    • van Overbeeke E.J.
    • Wegner I.,.
    • Pothen A.J.
    Prognostic value of continued smoking on survival and recurrence rates in patients with head and neck cancer: A systematic review.
    Head & neck. 2016; 38: E2214-E2220
    View in Article

    • Google Scholar
14. NRG-HN003 Cisplatin, Intensity-Modulated radiation therapy, and Pembrolizumab in treating patients with stage III-IV head and neck squamous cell carcinoma.
    (Available at:)
    https://clinicaltrials.gov/ct2/show/NCT02775812

    Date: 2018
    (Accessed January 1, 2022)
    View in Article

    • Google Scholar
15. • Bonner J.A.
    • Harari P.M.
    • Giralt J.
    • et al.
    Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
    N Engl J Med. 2006; 354: 567-578
    View in Article

    • Google Scholar
16. • Gillison M.L.
    • Trotti A.M.
    • Harris J.
    • et al.
    Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
    Lancet. 2019; 393: 40-50
    View in Article

    • Google Scholar
17. Radiation therapy with durvalumab or cetuximab in treating patients with locoregionally advanced head and neck cancer who cannot Take Cisplatin.
    (Available at:)
    https://clinicaltrials.gov/ct2/show/NCT03258554

    Date: 2017
    (Accessed January 1, 2022)
    View in Article

    • Google Scholar
18. Dose-Escalated Hypofractionated Adaptive Radiotherapy for head and neck cancer.
    (Available at:)
    https://clinicaltrials.gov/ct2/show/NCT04477759

    Date: 2020
    (Accessed January 1, 2022)
    View in Article

    • Google Scholar
19. • Yom S.S.
    • Torres-Saavedra P.
    • Caudell J.J.
    • et al.
    Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).
    J Clin Oncol. 2021; 39: 956-965
    View in Article

    • Google Scholar
20. De-intensified radiation therapy with CHEMOTHERAPY (Cisplatin) or IMMUNOTHERAPY (NIVOLUMAB) in treating patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal cancer.
    (Available at:)
    https://clinicaltrials.gov/ct2/show/NCT03952585

    Date: 2019
    (Accessed January 1, 2022)
    View in Article

    • Google Scholar
21. • Ferris R.L.
    • Flamand Y.
    • Weinstein G.S.
    • et al.
    Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).
    J Clin Oncol. 2020; 38: 6500
    View in Article

    • Google Scholar
22. • Nichols A.C.
    • Theurer J.
    • Prisman E.
    • Read N.
    • Berthelet E.
    • Tran E.,.
    • Palma D.A.
    Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Lancet Oncol. 2019; 20: 1349-1359
    View in Article

    • Google Scholar
23. • Anderson C.M.
    • Lee C.M.
    • Saunders D.P.
    • et al.
    Phase IIb, Randomized, Double-Blind Trial of GC4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancer.
    J Clin Oncol. 2019; 37: 3256-3265
    View in Article

    • Google Scholar
24. Roman: A study to investigate the effects of gc4419 on radiation induced oral mucositis in patients with head/neck cancer.
    (Available at:)
    https://clinicaltrials.gov/ct2/show/NCT03689712

    Date: 2018
    (Accessed January 1, 2022)
    View in Article

    • Google Scholar
25. • Tsai C.J.
    • McBride S.M.
    • Riaz N.
    • et al.
    Reducing the Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus-Associated Oropharyngeal Carcinoma Being Treated With Primary Chemoradiotherapy at Memorial Sloan Kettering Cancer Center.
    Pract Radiat Oncol. 2019; 9: 98-101
    View in Article

    • Google Scholar
26. • Håkansson K.
    • Smulders B.
    • Specht L.
    • et al.
    Radiation dose-painting with protons vs. photons for head-and-neck cancer.
    Acta Oncol. 2020; 59: 525-533
    View in Article

    • Google Scholar
27. Study of proton versus photon beam radiotherapy in the treatment of head and neck cancer.
    (Available at:)
    https://clinicaltrials.gov/ct2/show/NCT02923570

    Date: 2016
    View in Article

    • Google Scholar